Dupuytren’s disease and heart disease: is there a link?

Dupuytren's disease causes lumps and thickened tissue in the palms of the hands, sometimes leading to bent fingers. Although it mainly affects the hands, researchers have also investigated whether people with Dupuytren's are more likely to develop cardiovascular disease, which includes heart disease and strokes.
Dr Richard Shaffer, Consultant Clinical Oncologist and medical reviewer

Medically reviewed by: Dr Richard Shaffer

Consultant Clinical Oncologist

Recent research suggests that there may be a connection. However, having Dupuytren’s doesn’t mean that you will develop heart disease or have a stroke, and there are plenty of things you can do to reduce your risk.

What have studies found about heart disease and Dupuytren's?

A large study from South Korea in 2025 found that people with Dupuytren’s disease were more likely to experience a heart attack or stroke than people without the condition. The researchers also investigated whether having Dupuytren’s affected the likelihood of surviving these events.

 

An earlier UK study from 2020 found an increased risk of death from cardiovascular disease over the longer term. 

 

Together, these studies suggest that the connection deserves attention, although they don’t establish that Dupuytren’s directly causes cardiovascular disease.

What did the 2025 South Korean study find?

Researchers in South Korea compared 35,909 people with Dupuytren’s disease with more than one million people without the condition. They used government health records to examine how often people experienced heart attacks and two different types of stroke. 

 

The initial results showed that people with Dupuytren’s had higher rates of heart attacks, ischaemic strokes and haemorrhagic strokes.

 

An ischaemic stroke occurs when a blood clot blocks blood flow to part of the brain. A haemorrhagic stroke occurs when a blood vessel bleeds in or around the brain.

 

The differences were substantial. For example, the rate of ischaemic stroke was approximately twice as high in people with Dupuytren’s. However, these initial comparisons didn’t take account of other factors that could explain some of the increased risk.

What happened when the researchers accounted for other risk factors?

Some of the factors that increase the risk of heart disease and stroke, including smoking and diabetes, also make people more likely to develop Dupuytren’s disease. This means that the higher rates of heart attacks and strokes might partly reflect differences in these risk factors between the two groups.

 

The researchers therefore adjusted their calculations to take account of other factors that affect cardiovascular health. In simple terms, they tried to make a fairer comparison by allowing for differences in people’s existing health risks.

 

Even after making these adjustments, people with Dupuytren’s still had an increased risk of ischaemic stroke. However, an increased risk of haemorrhagic stroke was no longer clearly established, and the increased risk of heart attack was only identified in certain groups, particularly people under 50.

 

The strongest overall finding was therefore the increased risk of ischaemic stroke. The study suggests that this connection cannot be explained entirely by the cardiovascular risk factors that the researchers took into account.

What did the earlier UK study find?

A UK study published in 2020 compared nearly 42,000 people with Dupuytren’s disease with 210,000 people without it. Rather than examining the total number of people who had a heart attack or a stroke, the researchers investigated how many people in each group died from these conditions. 

 

They found that people with Dupuytren’s had a lower risk of dying from cardiovascular disease during the first 12 years after diagnosis. After 12 years, however, the risk was 38% higher, even after taking into account smoking, diabetes and body weight.

 

For more information about the UK study and its wider findings, see the blog on Dupuytren’s disease and life expectancy.

Why might Dupuytren's be linked to heart disease and stroke?

One possible explanation is that Dupuytren’s and cardiovascular disease share some of the same risk factors. Smoking and diabetes both make people more likely to develop Dupuytren’s disease, and they also increase the risk of heart attacks and strokes.

 

This may explain some of the connection found in the studies. However, the South Korean researchers still found an increased risk of ischaemic stroke after taking other risk factors into account. This suggests that something else may be contributing to the increased risk.

 

For example, some of the genes and biological processes that contribute to Dupuytren’s disease might also increase the likelihood of developing cardiovascular disease. More research is needed to establish whether there is such a connection, and if so, why it occurs.

How can you reduce your risk of heart disease and stroke?

If you have Dupuytren’s disease, these findings are another reason to pay attention to your cardiovascular health. The good news is that there’s plenty you can do to reduce your risk.

 

Some useful steps include:

 

These changes can reduce your risk of heart disease and stroke, whether or not you have Dupuytren’s. If you’re concerned about your cardiovascular health, your GP can help you assess your risk and decide whether any further checks are needed.

 

Having Dupuytren’s disease alone doesn’t mean that you automatically need heart tests or scans.

What does this mean for your future health?

Research suggests that people with Dupuytren’s disease may have a higher risk of heart attacks and certain types of stroke. Knowing about this possible connection gives you an opportunity to take action and reduce your risk.

 

Stopping smoking, managing diabetes and looking after your cardiovascular health could make a real difference to your future health. It’s worth treating these findings as a reminder to take care of the things you can influence, rather than as a prediction of what will happen to you.

 

If you’re also wondering whether having Dupuytren’s disease affects how long people live, our article on Dupuytren’s disease and life expectancy explores that question in more detail.

OK, so what about my hands?

You may also have questions about Dupuytren’s disease itself, including whether it will progress and when treatment might be appropriate. Our guide to treatments for Dupuytren’s disease explains the different treatment options, when they may be suitable and what you can expect from them.

 

If you are thinking about radiotherapy for early-stage Dupuytren’s, you can read about radiotherapy treatment for Dupuytren’s disease in the UK, or arrange a consultation to discuss your own hands with our team.

References

Ryu JY, Park TH, Lee JS, Choi KY, Yang JD, Chung HY. Risk and mortality of cardiovascular diseases in patients with Dupuytren disease: a nationwide population-based cohort study. Plastic and Reconstructive Surgery. 2025;156(1):93–101. doi:10.1097/PRS.0000000000011944

 

Kuo RYL, Ng M, Prieto-Alhambra D, Furniss D. Dupuytren’s disease predicts increased all-cause and cancer-specific mortality: analysis of a large cohort from the U.K. Clinical Practice Research Datalink. Plastic and Reconstructive Surgery. 2020;145(3):574–582. doi:10.1097/PRS.0000000000006551

Expert-Led Radiotherapy for Dupuytren’s and Ledderhose Disease

Every case of Dupuytren’s or Ledderhose disease is different. Dr Richard Shaffer can assess your condition and help you understand whether radiotherapy may be suitable. Take the next step towards an informed treatment decision.

Related Posts

Get a call from Dr Shaffer’s team

Concerned about Dupuytren's Contracture or Ledderhose Disease? Book your free call to discuss how we can help.